Curexsys GmbH
PrivateLast Round
Seed
Dec 9, 2020
Total Funding Raised
$9.97M
Company Overview
Curexsys GmbH is a biotechnology company that develops therapeutic exosome-based treatments for age-related and inflammatory conditions using a proprietary traceless immune-affinity isolation technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curexsys GmbH Comparables
Compare Curexsys GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EVerZom | 80% | |
| ConvEyXO | 79% | |
| Carrier Biomed (Suzhou) Co., Ltd. | 77% | |
Curexsys GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 9, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2020
$10M round led by Evotec and Sartorius Aktiengesellschaft.
Curexsys GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curexsys GmbH's valuation, stock price, and market status.